Sites · coordinators · 4 minutes reading

Clinical trials digest

Investigators, study nurses, and the site team

Sites collect the study. The principal investigator, sub-investigators, study coordinators, and research nurses share one participant list, one schedule of activities, and one query inbox.

Study nurseCoordinatorInvestigatorSites
← All articles

4 min

Reading time

EU+US

Doctors and sites

1 record

Drug, device, IVD

The people who actually collect the trial

Sponsors write protocols. Authorities read packages. Sites collect the study. The principal investigator carries the medical duty. Sub-investigators cover clinics the PI cannot sit. The study coordinator or research nurse is the person who knows whether visit three is windowed this Thursday, whether the consent is the current version, and whether a query is still open. Pharmacists account for product. Laboratory staff account for kits and specimens. If those people do not share one participant list, the trial becomes a set of inboxes. ValidTrials is built around the site team that already exists in a clinic, not around a vendor’s idea of a “user seat.”

The people who actually collect the trial

Full article for doctors, investigators, and readers who follow clinical trials.

One schedule of activities

The protocol’s schedule of activities is the clinic’s calendar. Screening, baseline, treatment visits, follow-up, unscheduled safety visits — each with forms, windows, and procedures. A coordinator who has to reconstruct that calendar from a PDF and a spreadsheet will miss a window. ValidTrials stores the schedule with a target day and window for each visit, and a visit date outside its window opens a query. A per-participant worklist of overdue forms is not built yet. We configure the schedule from the protocol so the site does not invent a parallel tracker.

Queries without a second login

Monitors and data managers open queries when a value is missing, out of range, or inconsistent. The worst version of that process is an email to a generic clinic address, a screenshot, and a week of silence. The better version is a query on the same form the nurse is already filling, with a person, a timestamp, and a close. Individual accounts mean the monitor sees the trail without borrowing the nurse’s password. ValidTrials limits a study to its named members; it does not yet separate sites within a study. That is ordinary GCP. It is still rare in small sites running their first device or IVD study. This digest is written in the language we use on those openings.

Queries without a second login

Full article for doctors, investigators, and readers who follow clinical trials.

Medical coding and the source

Adverse events, medications, and medical history have to be coded if the package is going to an authority. MedDRA and WHODrug are the usual dictionaries for drugs. Device and diagnostic studies add product codes, UDI, and specimen identifiers. Coding is not the nurse’s night job. Capture at the site should be clinical language. Coding happens in the same record, with an audit trail, so the source and the coded term do not drift apart in two files. Doctors and coordinators who subscribe get short notes on what they must enter versus what the CRO codes on their behalf.

Delegation, training, and the log the inspector asks for

The delegation log names who may consent, who may dispense, who may sign a CRF. Training records show that those people saw the current protocol. Inspectors ask for both before they look at a participant. In ValidTrials, training and delegation are tracked items on the study, and a signed delegation log is filed in the TMF. When a staff member leaves, their account is disabled and their past entries stay attributable. Linking retraining to a protocol amendment is still a manual step.

Delegation, training, and the log the inspector asks for

Full article for doctors, investigators, and readers who follow clinical trials.

Read more from the digest.

Subscribe, or bring us the protocol.

The digest is for doctors and trial readers. The study conversation starts with us.